Sherri L. Andis

LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.

C Shih, V J Chen, Lynn S. Gossett et al. · PubMed · 1997 · 565 citations

Multiple Folate-requiring Enzymes, Medicinal Chemistry, Biochemistry +14

Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane- 2,6-dicarboxylic Acid (LY354740):  Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate Receptors

James A. Monn, Matthew J. Valli, Steven M. Massey et al. · Journal of Medicinal Chemistry · 1999 · 286 citations · Full text

Active Agonists, Mglu Receptors, Pharmacotherapy +16

In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin.

Richard M. Schultz, Ronald L. Merriman, Sherri L. Andis et al. · PubMed · 1995 · 113 citations

Chemoprevention Strategy, Mitogenic Signals, Immunology +16

Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis

John L. Tonkinson, Philip Marder, Sherri L. Andis et al. · Cancer Chemotherapy and Pharmacology · 1997 · 82 citations

Biochemistry, Cell Division, Medicine +11

Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.

Lillian L. Habeck, L G Mendelsohn, C Shih et al. · Molecular Pharmacology · 1995 · 67 citations